(Created page with "= Tuesday 6<sup>th</sup> September= ==Lab work== ===Visualization=== ====Q5 PCR on dCas9 ST - GFP 11 in pSB1C3, FRB in pJET and GFP 1.9 in pUC19 ==== ''By Maxence'' Q5 PCR w...") |
(→Lab work) |
||
(17 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
+ | {{Team:Paris_Saclay/notebook_header}} | ||
= Tuesday 6<sup>th</sup> September= | = Tuesday 6<sup>th</sup> September= | ||
− | + | ||
===Visualization=== | ===Visualization=== | ||
====Q5 PCR on dCas9 ST - GFP 11 in pSB1C3, FRB in pJET and GFP 1.9 in pUC19 ==== | ====Q5 PCR on dCas9 ST - GFP 11 in pSB1C3, FRB in pJET and GFP 1.9 in pUC19 ==== | ||
− | ''By Maxence'' | + | ''By Maxence & Mahnaz'' |
Q5 PCR was performed on plasmids with the following protocol: | Q5 PCR was performed on plasmids with the following protocol: | ||
For each 50μl of reaction, mix the following reagents : | For each 50μl of reaction, mix the following reagents : | ||
− | * | + | * 1 µL of plasmid |
− | * | + | * 1 µL of dNTPs (10mM) |
− | * | + | * 1 µL of each primer mix (10µM) |
− | * | + | * 10 µL of Q5 buffer (5X) |
− | * 0, | + | * 0,5 µL of Q5 high fidelity polymerase |
− | * 35, | + | * 35,5 µL of nuclease free water |
− | Mix gently and aliquot | + | Mix gently and aliquot 50 μl of the mix into the PCR tubes on ice. |
Perform PCR as follow: | Perform PCR as follow: | ||
{| class="wikitable" | {| class="wikitable" | ||
Line 47: | Line 48: | ||
|} | |} | ||
− | + | [[Team:Paris_Saclay/Experiments#primers|Primers]] used were: | |
{| class="wikitable" | {| class="wikitable" | ||
Line 73: | Line 74: | ||
====PCR Clean-up of PCR products ==== | ====PCR Clean-up of PCR products ==== | ||
− | ''By Maxence'' | + | ''By Maxence & Mahnaz'' |
PCR products obtained were cleaned up by using the NucleoSpin Gel and PCR Clean-up kit [[Team:Paris_Saclay/Experiments#Purification|protocol]]. | PCR products obtained were cleaned up by using the NucleoSpin Gel and PCR Clean-up kit [[Team:Paris_Saclay/Experiments#Purification|protocol]]. | ||
====NanoDrop Measurements==== | ====NanoDrop Measurements==== | ||
− | ''By Maxence'' | + | ''By Maxence & Mahnaz'' |
{| class="wikitable" | {| class="wikitable" | ||
Line 84: | Line 85: | ||
!Concentration (ng/µL) | !Concentration (ng/µL) | ||
|- | |- | ||
− | |PCR fragment GFP 11 clone 6 | + | |PCR fragment GFP 11 clone 6<div id="PCR fragment GFP 11 - pSB1C3 clones 6"></div> |
|187.23 | |187.23 | ||
|- | |- | ||
− | |PCR fragment GFP 11 clone 8 | + | |PCR fragment GFP 11 clone 8<div id="PCR fragment GFP 11 - pSB1C3 clones 8"></div> |
|156.85 | |156.85 | ||
|- | |- | ||
− | |PCR fragment FRB clone 4 | + | |PCR fragment FRB clone 4<div id="PCR fragment FRB clone 4"></div> |
|75.67 | |75.67 | ||
|- | |- | ||
− | |PCR fragment FRB clone 9 | + | |PCR fragment FRB clone 9<div id="PCR fragment FRB clone 9"></div> |
|246.41 | |246.41 | ||
|- | |- | ||
− | |PCR fragment GFP 1.9 | + | |PCR fragment GFP 1.9<div id="PCR fragment GFP 1.9"></div> |
|22.06 | |22.06 | ||
|- | |- | ||
Line 102: | Line 103: | ||
====Gel of cleaned up PCR products==== | ====Gel of cleaned up PCR products==== | ||
− | ''By Maxence'' | + | ''By Maxence & Mahnaz'' |
After amplification, 3 µL of each cleaned up PCR products and 5 µL of DNA ladder were placed in wells and migrated at 100V during 30 min. | After amplification, 3 µL of each cleaned up PCR products and 5 µL of DNA ladder were placed in wells and migrated at 100V during 30 min. | ||
Line 120: | Line 121: | ||
|- | |- | ||
|GFP 1.9 | |GFP 1.9 | ||
− | | | + | |862 |
|} | |} | ||
− | [[File:T--Paris Saclay-- | + | [[File:T--Paris Saclay--Gel111.png|400px|thumb|center|Result of the migration]] |
− | + | No PCR products were obtained for GFP 1.9. Concerning FRB and GFP 11 - pSB1C3 amplification, good results were obtained and clones 9 for FRB and clone 8 for GFP 11 - pSB1C3 were selectionned. | |
====Linearization of PCR product GFP 11 - pSB1C3 from clone 8==== | ====Linearization of PCR product GFP 11 - pSB1C3 from clone 8==== | ||
− | ''By Maxence'' | + | ''By Maxence & Mahnaz'' |
PCR product GFP 11 - pSB1C3 has been linearized for further Gibson application by using DpnI treatment : | PCR product GFP 11 - pSB1C3 has been linearized for further Gibson application by using DpnI treatment : | ||
− | * | + | * 30 µL of cleaned up PCR product GFP 11 - pSB1C3 |
− | * | + | * 4 µL of fast digest buffer |
− | * | + | * 1 µL of DpnI |
− | * | + | * 5 µL of water |
The mix was placed 10 minutes at 37°C and was cleaned by using the NucleoSpin Gel and PCR Clean-up kit [[Team:Paris_Saclay/Experiments#Purification|protocol]]. | The mix was placed 10 minutes at 37°C and was cleaned by using the NucleoSpin Gel and PCR Clean-up kit [[Team:Paris_Saclay/Experiments#Purification|protocol]]. | ||
+ | |||
+ | ====Transformation of DH5a cells with dCas9 NM - GFP 10 in PSB1C3 (pPS16_016) obtained by Gibson==== | ||
+ | ''By Maxence & Mahnaz'' | ||
+ | |||
+ | Dh5a cells were transformed with pSB1C3 containing dCas9 NM - GFP 10 (pPS16_016) (obtained by Gibson of fragment 1 PCR products (one with Q5 Pol and one with Phusion) + fragment 2 PCR products (one with Q5 Pol and one with Phusion) + pSB1C3), or containing control (no mix added when Gibson performed) using the usual [[Team:Paris_Saclay/Experiments#heat-shocktransformation|protocol]]. | ||
+ | {{Team:Paris_Saclay/notebook_footer}} |
Latest revision as of 17:02, 9 October 2016